Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

 

3. Osiris strikes deal with Stryker for bone-repair product

Osiris Therapeutics said it struck an exclusive marketing deal with Stryker for its Bio4 bone allograft.

The agreement calls for Stryker to market and commercialize Bio4 worldwide, with Osiris responsible for manufacturing and ongoing product research. Read more

2. Stryker buys British hospital bed maker CHG

Stryker, as expected, opened 2015 with the acquisition of a British company, just not the 1 most anticipated by observers.

The Kalamazoo, Mich.-based medical device giant is rumored to be near an offer for British rival Smith & Nephew. But Stryker said it picked up privately held CHG Hospital Beds for an undisclosed amount. Read more

1. FDA approves Medtronic’s In.Pact Admiral balloon

Medtronic said that the FDA approved its In.Pact Admiral drug-eluting balloon for treating peripheral artery disease in the upper leg.

Medtronic touted the In.Pact Admiral as having demonstrated “the best clinical outcomes ever reported for this disease state.” Read more